Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$1.65 - $2.39 $11,421 - $16,543
-6,922 Reduced 51.08%
6,628 $11,000
Q1 2024

Apr 25, 2024

BUY
$1.89 - $2.85 $22,218 - $33,504
11,756 Added 655.3%
13,550 $31,000
Q4 2023

Feb 02, 2024

SELL
$1.15 - $2.21 $14,829 - $28,497
-12,895 Reduced 87.79%
1,794 $3,000
Q3 2023

Nov 01, 2023

BUY
$1.3 - $1.77 $10,606 - $14,441
8,159 Added 124.95%
14,689 $19,000
Q2 2023

Aug 04, 2023

SELL
$1.62 - $2.32 $128,987 - $184,723
-79,622 Reduced 92.42%
6,530 $10,000
Q1 2023

Apr 27, 2023

BUY
$1.99 - $3.66 $101,066 - $185,880
50,787 Added 143.61%
86,152 $183,000
Q4 2022

Feb 02, 2023

BUY
$0.8 - $3.7 $26,337 - $121,811
32,922 Added 1347.61%
35,365 $130,000
Q3 2022

Nov 04, 2022

BUY
$0.74 - $0.89 $1,776 - $2,136
2,400 Added 5581.4%
2,443 $1,000
Q2 2022

Aug 03, 2022

BUY
$0.56 - $1.0 $24 - $43
43 New
43 $0
Q1 2022

May 02, 2022

SELL
$0.9 - $8.39 $14,661 - $136,681
-16,291 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$6.58 - $8.44 $107,194 - $137,496
16,291 New
16,291 $130,000
Q2 2021

Aug 12, 2021

SELL
$5.75 - $7.59 $702,552 - $927,368
-122,183 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$4.14 - $9.22 $493,471 - $1.1 Million
119,196 Added 3990.49%
122,183 $807,000
Q4 2020

Feb 02, 2021

BUY
$3.58 - $4.85 $10,636 - $14,409
2,971 Added 18568.75%
2,987 $12,000
Q3 2020

Oct 14, 2020

SELL
$4.79 - $6.3 $8,799 - $11,573
-1,837 Reduced 99.14%
16 $0
Q2 2020

Jul 13, 2020

SELL
$4.5 - $6.53 $101,839 - $147,780
-22,631 Reduced 92.43%
1,853 $11,000
Q1 2020

Apr 29, 2020

BUY
$5.25 - $9.9 $128,541 - $242,391
24,484 New
24,484 $134,000
Q4 2019

Feb 05, 2020

SELL
$5.84 - $10.51 $584 - $1,051
-100 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$5.76 - $9.44 $576 - $944
100 New
100 $0
Q2 2019

Jul 26, 2019

SELL
$9.1 - $15.55 $473 - $808
-52 Closed
0 $0
Q1 2019

Apr 18, 2019

BUY
$12.5 - $18.48 $650 - $960
52 New
52 $0

Others Institutions Holding PRQR

About ProQR Therapeutics N.V.


  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $191M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.